Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls

Schizophrenia Research

Volumn 122, Issue 1-3, 2010, Pages 31-37

  Wirgenes, Katrine V ^a,b   Djurovic, Srdjan ^a,b   Sundet, Kjetil ^a   Agartz, Ingrid ^a,c   Mattingsdal, Morten ^a   Athanasiu, Lavinia ^a,b   Melle, Ingrid ^a,b   Andreassen, Ole A ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

Bipolar disorder; Catechol O methyltransferase; Dopamine; Neurocognition; Prefrontal cortex; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; BIPOLAR DISORDER; COGNITION; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; WORKING MEMORY;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; COGNITION DISORDERS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHIONINE; NEUROPSYCHOLOGICAL TESTS; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; VALINE;

EID: 77956192325     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.05.007     Document Type: Article

References (49)

1. Barnett J.H., Heron J., Ring S.M., Golding J., Goldman D., Xu K., Jones P.B. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am. J. Psychiatry 2007, 164:142-149.
2. Barnett J.H., Scoriels L., Munafo M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol. Psychiatry 2008, 64:137-144.
3. bi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int. J. Neuropsychopharmacol. 2004, 7(Suppl. 1):S1-S5.
4. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 2004, 75:807-821.
5. Craddock N., O'Donovan M.C., Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 2006, 32:9-16.
6. Craddock N., Owen M.J., O'Donovan M.C. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol. Psychiatry 2006, 11:446-458.
7. Crow T.J. Nature of the genetic contribution to psychotic illness-a continuum viewpoint. Acta Psychiatr. Scand. 1990, 81:401-408.
8. Daban C., Martinez-Aran A., Torrent C., Tabares-Seisdedos R., Balanza-Martinez V., Salazar-Fraile J., Selva-Vera G., Vieta E. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother. Psychosom. 2006, 75:72-84.
9. Delis D.C., Kaplan E., Kramer J.H. Delis-Kaplan Executive Function System (D-KEFS) Norwegian Manual 2005, Pearson Assessment, Stockholm.
10. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test - Second Edition (CVLT-II). Norwegian Manual supplement 2004, Pearson Assessment, Stockholm.
11. Diaz-Asper C.M., Goldberg T.E., Kolachana B.S., Straub R.E., Egan M.F., Weinberger D.R. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol. Psychiatry 2008, 63:72-79.
12. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6917-6922.
13. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., Feng G.Y., St C.D., He L. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry 2005, 57:139-144.
14. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 2003, 160:469-476.
15. Goldman D., Weinberger D.R., Malhotra A.K., Goldberg T.E. The role of COMT Val158Met in cognition. Biol. Psychiatry 2009, 65:e1-e2.
16. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
17. Gutierrez B., Bertranpetit J., Guillamat R., Valles V., Arranz M.J., Kerwin R., Fananas L. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am. J. Psychiatry 1997, 154:113-115.
18. Haatveit, B.C., Sundet, K., Hugdal, K., Ueland, T., Melle, I., & Andreaasen, O.A. (in press, accepted December 2009) The validity of d-prime as a working memory index: Results from the "Bergen n-back task". Journal of Clinical and Experimental Neuropsychology. http://doi:10.1080/13803391003596421.
19. Hardy J., Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 2009, 360:1759-1768.
20. Harrison P.J., Tunbridge E.M. Catechol-O-Methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2007, 33:3037-3045.
21. Hill S.K., Harris M.S., Herbener E.S., Pavuluri M., Sweeney J.A. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr. Bull. 2008, 34:743-759.
22. Hoenicka J., Garrido E., Martinez I., Ponce G., Aragues M., Rodriguez-Jimenez R., Espana-Serrano L., Alvira-Botero X., Santos J.L., Rubio G., Jimenez-Arriero M.A., Palomo T. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 153B:79-85.
23. Kunugi H., Vallada H.P., Hoda F., Kirov G., Gill M., Aitchison K.J., Ball D., Arranz M.J., Murray R.M., Collier D.A. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biol. Psychiatry 1997, 42:282-285.
24. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
25. Mata I., Arranz M.J., Staddon S., Lopez-Ilundain J.M., Tabares-Seisdedos R., Murray R.M. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis. Psychiatr. Genet. 2006, 16:213-216.
26. Matsumoto M., Weickert C.S., Akil M., Lipska B.K., Hyde T.M., Herman M.M., Kleinman J.E., Weinberger D.R. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 2003, 116:127-137.
27. Mier D., Kirsch P., Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry 2009, doi:10.1038/mp.2009.36.
28. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Owen M.J., O'Donovan M.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 2009, 14:252-260.
29. Munafo M.R., Bowes L., Clark T.G., Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol. Psychiatry 2005, 10:765-770.
30. Nolan K.A., Bilder R.M., Lachman H.M., Volavka J. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am. J. Psychiatry 2004, 161:359-361.
31. O'Donovan M.C., Craddock N.J., Owen M.J. Genetics of psychosis; insights from views across the genome. Hum. Genet. 2009, 126:3-12.
32. O'Hara R., Miller E., Liao C.P., Way N., Lin X., Hallmayer J. COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci. Lett. 2006, 409:205-209.
33. Pooley E.C., Fineberg N., Harrison P.J. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol. Psychiatry 2007, 12:556-561.
34. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Howes O., Kravariti E., Demjaha A., Toulopoulou T., Diforti M., Murray R.M., Collier D.A., McGuire P.K. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol. Psychiatry 2009, 65:473-480.
35. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Toulopoulou T., Bramon E., Walshe M., Murray R.M., Collier D.A., McGuire P. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13600-13605.
36. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
37. Rybakowski J.K., Borkowska A., Czerski P.M., Hauser J. Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene. Psychiatry Res. 2002, 113:49-57.
38. Rypma B. Factors controlling neural activity during delayed-response task performance: testing a memory organization hypothesis of prefrontal function. Neuroscience 2006, 139:223-235.
39. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 1998, 18:2697-2708.
40. Shifman S., Bronstein M., Sternfeld M., Pisante A., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Yakir B., Zak N.B., Darvasi A. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 128B:61-64.
41. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch. Gen. Psychiatry 1992, 49:624-629.
42. Tan H.Y., Callicott J.H., Weinberger D.R. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex 2007, 17(Suppl. 1):i171-i181.
43. Tan H.Y., Chen Q., Sust S., Buckholtz J.W., Meyers J.D., Egan M.F., Mattay V.S., Meyer-Lindenberg A., Weinberger D.R., Callicott J.H. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12536-12541.
44. Tenhunen J., Salminen M., Lundstrom K., Kiviluoto T., Savolainen R., Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem. 1994, 223:1049-1059.
45. Ventura J., Liberman R.P., Green M.F., Shaner A., Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res. 1998, 79:163-173.
46. Wechsler D. Wechsler Memory Scale - Third Edition (WMS-III). Norwegian Manual 2007, Pearson Assessment, Stockholm.
47. Wechsler D. Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Norwegian Manual 2003, Pearson Assessment, Stockholm.
48. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., Berman K.F., Goldberg T.E. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 2001, 50:825-844.
49. Xie T., Ho S.L., Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol. 1999, 56:31-38.